Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids

被引:60
作者
Currais A. [1 ]
Quehenberger O. [2 ,3 ]
Armando A.M. [2 ]
Daugherty D. [1 ]
Maher P. [1 ]
Schubert D. [1 ]
机构
[1] Cellular Neurobiology Laboratory, The Salk Institute for Biological Studies, La Jolla, CA
[2] Department of Pharmacology, University of California San Diego, La Jolla, CA
[3] Department of Medicine, University of California San Diego, La Jolla, CA
来源
npj Aging and Mechanisms of Disease | / 2卷 / 1期
基金
美国国家卫生研究院;
关键词
D O I
10.1038/npjamd.2016.12
中图分类号
学科分类号
摘要
The beta amyloid (Aβ) and other aggregating proteins in the brain increase with age and are frequently found within neurons. The mechanistic relationship between intracellular amyloid, aging and neurodegeneration is not, however, well understood. We use a proteotoxicity model based upon the inducible expression of Aβ in a human central nervous system nerve cell line to characterize a distinct form of nerve cell death caused by intracellular Aβ. It is shown that intracellular Aβ initiates a toxic inflammatory response leading to the cell's demise. Aβ induces the expression of multiple proinflammatory genes and an increase in both arachidonic acid and eicosanoids, including prostaglandins that are neuroprotective and leukotrienes that potentiate death. Cannabinoids such as tetrahydrocannabinol stimulate the removal of intraneuronal Aβ, block the inflammatory response, and are protective. Altogether these data show that there is a complex and likely autocatalytic inflammatory response within nerve cells caused by the accumulation of intracellular Aβ, and that this early form of proteotoxicity can be blocked by the activation of cannabinoid receptors. © 2016 Japanese Society of Anti-Aging Medicine/Macmillan Publishers Limited.
引用
收藏
相关论文
共 51 条
[1]  
Prior M., Et al., Back to the future with phenotypic screening, ACS Chem. Neurosci., 5, pp. 503-513, (2014)
[2]  
Simonsen A., Et al., Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila, Autophagy, 4, pp. 176-184, (2008)
[3]  
Bayer T.A., Wirths O., Intracellular accumulation of amyloid-Beta—a predictor for synaptic dysfunction and neuron loss in Alzheimer's disease. Front, Aging Neurosci, 2, (2010)
[4]  
Lauritzen I., Et al., The beta-secretase-derived C-terminal fragment of betaAPP, C99, but not Abeta, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus, J. Neurosci, 32, pp. 16243-16255a, (2012)
[5]  
Tampellini D., Et al., Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice, J. Neurosci., 30, pp. 14299-14304, (2010)
[6]  
Wirths O., Et al., Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice, Neurosci. Lett., 306, pp. 116-120, (2001)
[7]  
Billings L.M., Oddo S., Green K.N., McGaugh J.L., Laferla F.M., Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice, Neuron, 45, pp. 675-688, (2005)
[8]  
Gouras G.K., Almeida C.G., Takahashi R.H., Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease, Neurobiol. Aging, 26, pp. 1235-1244, (2005)
[9]  
Li W., Et al., Stabilization of alpha-synuclein protein with aging and familial parkinson's disease-linked A53T mutation, J. Neurosci., 24, pp. 7400-7409, (2004)
[10]  
Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., Finkbeiner S., Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death, Nature, 431, pp. 805-810, (2004)